HEI (Minneapolis) reported the listing of its common stock was transferred to The NASDAQ Capital Market at the opening of business Thursday. The trading symbol for the company’s common stock, “HEII,” will not change. On Dec. 5 HEI received a notice from the Listing Qualifications Department of The NASDAQ Stock Market indicating that, based on the company’s Form 10-K for the period ended Sept. 2, HEI’s stockholders’ equity did not comply with the minimum $10,000,000 stockholders’ equity requirement for continued listing on The NASDAQ Global Market. HEI makes microelectronics, subsystems, systems, connectivity and software solutions for OEMs engaged for the medical equipment and medical device, hearing, communications, and industrial markets.

Report: safety syringe sector to grow

While more that 50 companies compete in the safety syringe sector, about two-dozen companies manufacture and/or market safety syringes that influence the competitive landscape. Alliance agreements, such as the recently announced marketing and distribution agreement between Inviro Medical (Duluth, Georgia) and Formosa Medical (Taipei, Taiwan), will continue to be a factor in shaping this sector, with technology licensing to continue to play an important role in the market for safety syringes in general and retractable syringes in particular.

These findings are contained in a new report: “Retractable Safety Syringes: Players, Products, and Prospects,” which forecasts gains in clinical market share for retractable safety syringes with caregiver-friendly features and improved economics.

While safety syringe products encompass a broad range of design approaches including manual and auto-disabling devices, retractable syringes represent the most elegant approach to addressing the caregiver sharps risk issue by de-emphasizing the need for a sharps disposal step. New retractable designs address caregiver preferences and mitigate the cost premium associated with retractable models, according to the report.